Industry Overview
The Indian drugs and pharmaceuticals industry has developed substantially alongside the country's planned economic expansion and growing healthcare needs, making it one of India's leading industries. India now produces a wide variety of pharmaceutical products. Oncology is the branch of medicine concerned with the study and treatment of cancer, a disease characterized by abnormal cells growing and dividing without control.
Oncology drugs are used in the diagnosis and treatment of various cancers, including blood, endocrine, lung, bone, skin, genitourinary, gastrointestinal, breast, eye, head and neck, and gynaecologic cancers. Based on treatment approaches, the oncology drugs market includes chemotherapy, immunotherapy, surgery, radiation therapy, stem cell transplant, hormone therapy and other treatments.
North America, followed by Europe, has the largest oncology drugs market, supported by new drug development, government initiatives and developed healthcare infrastructure. Asia is expected to experience significant growth due to increasing cancer incidence, tobacco use and an ageing population. Technological advancement, growing R&D requirements, new drugs and therapies, and healthcare support are important market drivers. However, high treatment costs, strict regulations, substantial clinical-development investment and treatment side effects remain key restraints. Personalized medicine, product launches, collaborations, partnerships, and mergers and acquisitions are among the notable industry trends.
Cost Estimation
| Particulars | Value |
|---|---|
| Plant Capacity | 270000 Nos/Day |
| Land & Building (6000 sq.mt.) | Rs. 4.83 Cr |
| Plant & Machinery | Rs. 5.85 Cr |
| Working Capital for 2 Months | Rs.23.16 Cr |
| Total Capital Investment | Rs. 34.55 Cr |
| Rate of Return | 47% |
| Break Even Point | 32% |
Content Index
- INTRODUCTION
- ONCOLOGY AND CRITICAL CARE
- ONCOLOGY AND ITS TREATMENT
- CHEMOTHERAPY
- SOLID TUMORS
- FOR LUNG CANCER
- FOR ORAL CANCER
- FOR COLORECTAL CANCER
- FOR PROSTATE
- FOR MRCC (MET. RENAL CELL CARCINOMA)
- IN WOMEN, THE MOST PREVALENT CANCERS ARE CERVIX, BREAST AND OVARY.
- FOR CERVIX CANCERS
- FOR BREAST CANCER
- IN OVARIAN CANCER
- HAEMATOLOGICAL MALIGNANCIES
- SUPPORTIVE THERAPY
- CRITICALLY ILL PATIENTS
- ANTICOAGULANTS
- MARKPARIN- ENOXAPARIN (40, 60 MG)
- PROPERTIES & CHARACTERISTICS OF INJECTION (DISTILLED WATER)
- CHARACTERISTICS OF INJECTABLES:-
- USES AND APPLICATIONS
- ADVANTAGES OF PARENTERAL PRODUCTS (INJECTABLES):-
- OXYTOCIN INJECTION (PITUITARY):-
- B.I.S. SPECIFICATION
- RAW MATERIALS FOR INJECTION DISTILLED WATER (DISTILLED WATER AMPOULES)
- WATER PROPERTIES
- KMNO4 (POTASIUM PERMANGANATE):-
- GLASS AMPOULES
- INJECTION WATER
- SALINE (NORMAL SALINE SOLUTION FOR INJECTION)
- ACIDITY OR ALKALINITY:-
- BARIUM:-
- CALCIUM AND MAGNESIUM:-
- HEAVY METALS:-
- MARKET OVERVIEW OF ONCOLOGY DRUGS
- THE ONCOLOGY DRUGS MARKET IS SEGMENTED BY TYPE INTO
- THE ONCOLOGY DRUGS MARKET IS SEGMENTED BY DRUG CLASS TYPE INTO
- THE ONCOLOGY DRUGS MARKET IS SEGMENTED BY DISTRIBUTION CHANNEL INTO
- THE ONCOLOGY DRUGS MARKET IS SEGMENTED BY ROUTE OF ADMINISTRATION INTO
- THE ONCOLOGY DRUGS MARKET IS SEGMENTED BY DRUG CLASSIFICATION INTO
- PRIME COMPETITORS IN THIS ONCOLOGY DRUGS MARKET ARE AS FOLLOWS:
- SOME OTHER PROMINENT COMPETITORS ARE AS FOLLOWS:
- FUTURE OF ONCOLOGY DRUGS
- ONCOLOGY DRUG MARKET IN INDIA
- FINDINGS FROM A STUDY CONCLUDED THE CANCER SCENARIO IN INDIA THAT:
- MARKET SIZE
- S.W.O.T. ANALYSIS
- STRENGTHS
- WEAKNESS
- OPPORTUNITIES
- INDUSTRY CHALLENGES
- LATEST DEVELOPMENTS IN INDIAN ONCOLOGY DEPARTMENT
- CIPLA:
- ZYDUS CADILA:
- BIOCON LTD.:
- NEW PLAYERS IN THE INDIAN ONCOLOGY MARKET
- AUROBINDO PHARMA LTD.:
- ALEMBIC PHARMA LTD.:
- GLOBAL ONCOLOGY MARKET AND PROCESS SOLUTION
- ONCOLOGY AND ITS TREATMENT
- CHEMOTHERAPY
- GENERIC DRUGS IN ONCOLOGY
- MANUFACTURING PROCESS OF INJECTION WATER
- FILLING OF AMPOULES
- PROCESS FLOW CHART
- PROCESSING OF PARENTRAL PRODUCTS INJECTIONS
- 1. ENVIRONMENTAL CONTROL:-
- TECHNIQUES INVOLVED IN THE PREPARATION OF INJECTABLES
- PACKING OF PARENTERAL PRODUCTS (PACKING OF INJECTABLES)
- PROCESSING OF CONTAINES & CLOSURES:-
- EVALUATION OF PARENTERAL PRODUCTS
- A. STERILITY TEST:-
- PYROGEN TEST:-
- CLARITY TESTS:-
- LEAKAGE TESTS:-
- FLOW DIAGRAM FOR PREPARATION OF INJECTABLES
- MANUFACTURING PROCESS OF INJECTIONS
- MANUFACTURING PROCESS OF TABLETS
- FLOW DIAGRAM OF TABLET MAKING PLANT
- CAPSULE FILLING AND SEALING
- (A) DILUENTS:
- (B) PROTECTIVE SORBENTS:
- (C) GLIDANTS:
- (D) ANTI-DUSTING COMPOUNDS:
- FILLING:
- SEALING AND LOCKING:
- FLOW DIAGRAM OF CAPSULE MAKING PLANT
- ONCOLOGY DRUGS
- FORMULATION OF LETROZOLE TABLETS
- FORMULATION OF ENZALUTAMIDE CAPSULES
- FORMULATION OF TEMOZOLOMIDE CAPSULE
- ADVANCED COLORECTAL CANCER
- ADJUVANT TREATMENT OF COLORECTAL CANCER
- ADVERSE EFFECTS
- DOSAGE AND ADMINISTRATION
- DOSAGE
- PRINCIPLES OF PLANT LAYOUT
- MAJOR PROVISIONS IN ROAD PLANNING FOR MULTIPURPOSE SERVICE ARE:
- PLANT LOCATION FACTORS
- PRIMARY FACTORS
- 1. RAW-MATERIAL SUPPLY:
- 2. MARKETS:
- 3. POWER AND FUEL SUPPLY:
- 4. WATER SUPPLY:
- 5. CLIMATE:
- 6. TRANSPORTATION:
- 7. WASTE DISPOSAL:
- 8. LABOR:
- 9. REGULATORY LAWS:
- 10. TAXES:
- 11. SITE CHARACTERISTICS:
- 12. COMMUNITY FACTORS:
- 13. VULNERABILITY TO WARTIME ATTACK:
- 14. FLOOD AND FIRE CONTROL:
- EXPLANATION OF TERMS USED IN THE PROJECT REPORT
- 1. DEPRECIATION:
- 2. FIXED ASSETS:
- 3. WORKING CAPITAL:
- 4. BREAK-EVEN POINT:
- 5. OTHER FIXED EXPENSES:
- 6. MARGIN MONEY:
- 7. TOTAL LOAD:
- 8. LAND AREA/MAN POWER RATIO:
- PROJECT IMPLEMENTATION SCHEDULES
- INTRODUCTION
- PROJECT HANDLING
- PROJECT SCHEDULING
- PROJECT CONSTRUCTION SCHEDULE
- TIME SCHEDULE
- SUPPLIERS OF PHARMACEUTICAL PLANTS AND MACHINERY
- SUPPLIERS OF RAW MATERIALS
Appendix
- APPENDIX – A:
- 01. PLANT ECONOMICS
- 02. LAND & BUILDING
- 03. PLANT AND MACHINERY
- 04. OTHER FIXED ASSESTS
- 05. FIXED CAPITAL
- 06. RAW MATERIAL
- 07. SALARY AND WAGES
- 08. UTILITIES AND OVERHEADS
- 09. TOTAL WORKING CAPITAL
- 10. TOTAL CAPITAL INVESTMENT
- 11. COST OF PRODUCTION
- 12. TURN OVER/ANNUM
- 13. BREAK EVEN POINT
- 14. RESOURCES FOR FINANCE
- 15. INSTALMENT PAYABLE IN 5 YEARS
- 16. DEPRECIATION CHART FOR 5 YEARS
- 17. PROFIT ANALYSIS FOR 5 YEARS
- 18. PROJECTED BALANCE SHEET FOR (5 YEARS)
Frequently Asked Questions
The oncology drugs industry focuses on medicines and therapies used in the diagnosis and treatment of cancer. It covers treatments for a broad range of cancers, including blood, lung, breast, gastrointestinal, bone, skin, genitourinary and gynaecologic cancers. Major treatment categories include chemotherapy, immunotherapy, hormone therapy, radiation therapy, stem cell transplantation and other approaches. The industry is influenced by cancer incidence, advances in medical technology, research and development, regulatory requirements, healthcare infrastructure and the introduction of new therapeutic products.
Oncology drugs are used in the management of many different types of cancer. The report identifies blood, endocrine, lung, bone, skin, genitourinary, gastrointestinal, breast, eye, head and neck, and gynaecologic cancers among the areas addressed by oncology therapies. The appropriate medicine and treatment approach depend on the cancer type, stage, biological characteristics and individual patient factors. Oncology treatment may involve chemotherapy, immunotherapy, hormone therapy, targeted approaches, radiation, surgery or combinations of these modalities.
The major treatment segments identified in the report are chemotherapy, immunotherapy, surgery, radiation therapy, stem cell transplant and hormone therapy. These approaches may be used individually or in combination depending on the cancer and treatment objective. The oncology market also includes different drug classes, distribution channels, routes of administration and drug classifications. Advances in drug development and growing research activity continue to broaden the range of treatment options available for cancer management.
Technological advancement, increasing cancer incidence and greater demand for cancer research are important drivers of the oncology drugs market. The report also identifies concerns about cancer mortality, the introduction of new drugs and therapies, and government support for improved healthcare as growth factors. In Asia, increasing cancer cases, tobacco use and an ageing population are identified as factors supporting market expansion. New product launches, personalized medicine, collaborations, partnerships and other forms of industry development also create opportunities for oncology drug manufacturers.
The oncology drugs industry faces high treatment costs, strict regulatory requirements and substantial investment requirements for drug development and clinical trials. The report also identifies side effects associated with cancer treatments as a significant restraint. Pharmaceutical manufacturers must therefore manage demanding research, development, manufacturing, quality and regulatory processes. The complexity of oncology therapies and the need to demonstrate safety and efficacy can also increase development timelines and investment requirements.
An oncology pharmaceutical project can involve multiple dosage-form and sterile-product manufacturing processes. The report covers injection water manufacturing, ampoule filling, parenteral product processing, environmental control, preparation and evaluation of injectables, tablet manufacturing, capsule filling and sealing, and formulations of selected oncology products. Manufacturing operations require appropriate controls for product quality, sterility where applicable, packaging, process validation and regulatory compliance. Specific manufacturing requirements depend on the dosage form and product being produced.
Plant location should consider raw-material supply, markets, power and fuel, water availability, climate, transportation, waste disposal, labour, regulatory laws and taxes. Site characteristics, community factors, flood and fire control and vulnerability to external risks are also identified in the report as location considerations. A pharmaceutical plant additionally requires suitable infrastructure and environmental and quality controls. Evaluating these factors together helps determine whether a proposed site can support reliable production, efficient logistics, regulatory compliance and long-term operational requirements.
Why Choose Us
- More than 45 years of experience
- Managed by expert industrial consultants
- ISO 9001-2015 Certified
- Registered under MSME, UAM No: DL01E0012000
How We Work
- 24/5 Research Support Get your queries resolved from an industry expert. Ask before you purchase.
- Custom Research Service Speak to our consultants to design an exclusive study for your needs.
- Quality Assurance All reports are prepared by qualified consultants & verified by experts.
- Information Security Your personal & confidential information is always safe and secure.
Detailed Project Report (DPR) includes Present Market Position and Expected Future Demand, Technology, Manufacturing Process, Investment Opportunity, Plant Economics and Project Financials. comprehensive analysis from industry covering detailed reporting and evaluates the position of the industry by providing insights to the SWOT analysis of the industry.
Each report include Plant Capacity, requirement of Land & Building, Plant & Machinery, Flow Sheet Diagram, Raw Materials detail with suppliers list, Total Capital Investment along with detailed calculation on Rate of Return, Break-Even Analysis and Profitability Analysis. The report also provides a birds eye view of the global industry with details on projected market size and then progresses to evaluate the industry in detail.
We can prepare detailed project report on any industry as per your requirement.
We can also modify the project capacity and project cost as per your requirement. If you are planning to start a business, contact us today.
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Key highlights
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge over major competitors
- An array of graphics, BEP analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth with an impact-analysis
- A clear understanding of the competitive landscape and key product segments
- Ask for FREE project related details with our consultant/industry expert.
- Share your specific research requirements for customized project report.
- Request for due diligence and consumer centric studies.
- Still haven't found what you're looking for? Speak to our Custom Research Team.
EIRI Board is a single destination for all the industry, company and country reports. We feature a large repository of latest industry reports, leading and niche company profiles, and market statistics prepared by highly qualified consultants and verified by a panel of experts.
Note: We can also prepare project report on any subject based on your requirement and country. If you need, we can modify the project capacity and project cost based on your requirement.
Our reports provide an expansive market analysis of the sector by covering areas like growth drivers, trends prevailing in the industry as well as comprehensive SWOT analysis of the sector.
Our Clients
- Our research reports comprehensively cover Indian markets (can be modified as per your country), present investigation, standpoint and gauge for a time of five years*.
- The market conjectures are produced on the premise of optional research and are cross-accepted through associations with the business players.
- We use dependable wellsprings of data and databases, and data from such sources is handled by us and incorporated into the report.
- Our project reports include detailed analysis that helps get the industry's Present Market Position and Expected Future Demand.
- Offer real analysis driving variables for the business and the most recent business sector patterns in the industry.
- This report comprehends the present status of the business by clarifying a complete SWOT examination and investigation of the interest-supply circumstance.
- Report gives analysis and in-depth financial comparison of real players/competitors.
- The report gives estimates of key parameters which forecast business execution.
